2012
DOI: 10.1093/jscr/2012.9.15
|View full text |Cite
|
Sign up to set email alerts
|

Giant biliary cystadenoma

Abstract: Biliary cystadenoma (BCA) is a rare cystic tumor which originates from intrahepatic or extrahepatic biliary ducts. Intrahepatic BCAs are more common, demonstrate a female predominance, and generally asymptomatic. Radiographic evaluation assists in the preoperative differentiation of these tumors from other cystic liver masses while resection remains the only means for definitive diagnosis. We report a case of massive mucinous intrahepatic BCA initially diagnosed as a nonresectable malignancy presenting in a fe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 8 publications
0
3
0
Order By: Relevance
“…Enucleation is a viable alternative in cases in which formal resection would be technically difficult or associated with excessive morbidity [45, 46]. Although only small case series are available, some have shown comparable results compared to formal hepatectomy, with few recurrences [9, 47].…”
Section: Discussionmentioning
confidence: 99%
“…Enucleation is a viable alternative in cases in which formal resection would be technically difficult or associated with excessive morbidity [45, 46]. Although only small case series are available, some have shown comparable results compared to formal hepatectomy, with few recurrences [9, 47].…”
Section: Discussionmentioning
confidence: 99%
“…The prognosis of hepatic cystadenomas is extremely good after complete resection. Inappropriate treatment, in particular aspiration or partial resection, is associated with a recurrence rate greater than 90% and a malignant degeneration risk of 30% [ 20 ].…”
Section: Discussionmentioning
confidence: 99%
“…Based on the location of origin symptoms may differ. 1,4 These are first described by Heuter in 1887. BCA is believed to be premalignant with risk of malignant transformation up to 20-30%.…”
Section: Introductionmentioning
confidence: 99%